granted
on 14 Mar 2024
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
97086744 filed on 21st Oct 2021
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use
No 97086744
No Service/Collective Mark
No 00160435-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
15th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
14th Mar 2024 | SOU EXTENSION 2 FILED |
14th Mar 2024 | SOU EXTENSION 2 GRANTED |
23rd Oct 2023 | ASSIGNED TO EXAMINER |
13th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
11th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
11th Oct 2023 | SOU EXTENSION 1 FILED |
11th Oct 2023 | SOU EXTENSION 1 GRANTED |
02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |